Anmelden Kostenlos registrieren

Adaptimmune Therapeutics Plc leerverkaufte Aktien zu allen Aktien

Was ist das leerverkaufte Aktien zu allen Aktien von Adaptimmune Therapeutics Plc?

leerverkaufte Aktien zu allen Aktien von Adaptimmune Therapeutics Plc ist 4.86

Was ist die Definition von leerverkaufte Aktien zu allen Aktien?



Das Leerverkauf-Verhältnis ist die Anzahl der leervekauften Aktien geteilt durch das durchschnittliche tägliche Volumen.

Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.

The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.

leerverkaufte Aktien zu allen Aktien von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Adaptimmune Therapeutics Plc

Was macht Adaptimmune Therapeutics Plc?

adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.

Unternehmen mit leerverkaufte aktien zu allen aktien ähnlich Adaptimmune Therapeutics Plc